Wearable Sensors in Healthcare
Among telehealth innovations, there’s a boom in wearable sensors that help medical professionals monitor patient health. They can detect anomalies, such as abnormal heart rhythms and high blood pressure.
They can also notice the onset of a disease at an early stage. This is possible because these devices are designed to continuously track vital signs.
In detecting coronary disease
For patients with coronary heart disease (CHD), wearables can provide an excellent mechanism for obtaining continuous physiologic data. These devices can be used to monitor and assess a variety of parameters, including blood pressure, heart rate, oxygen saturation, and activity.
In a clinical setting, these devices can help reduce the risk of cardiovascular events and enhance patient outcomes. Moreover, these devices can help improve patient satisfaction and alleviate staff workload.
Using body-worn sensors can help detect a wide range of hidden diseases, from hypertrophic cardiomyopathy (HCM) to pulmonary hypertension. These devices can also identify obstructed arteries and prevent heart attacks.
The technology is able to record and analyze a range of signals in a noninvasive manner. These signals can be influenced by a number of factors, such as body movement, contact degree with the skin, and noise. However, the raw data can be transformed into meaningful digital biomarkers through the use of appropriate signal quality assessment algorithms.
In detecting diabetes
Wearable sensors can capture data on a continual basis, and can provide real-time analytics to deliver actionable health insights to physicians, patients and caregivers. However, the utility of this information depends on the accuracy, quality and reliability of the device and its sensor.
First-generation wearables have focused on biophysical monitoring, such as physical activity, heart rate or body temperature, but second-generation devices are aiming to incorporate non-invasive and minimally invasive biochemical sensing. These devices can measure sweat, glucose or other biomarkers for detecting diabetes and other chronic diseases.
Sensors in the wearables industry typically use electromechanical, optical or electrochemical signal transduction methods to quantify a specific biomarker. To improve the sensitivity and specificity of their target analytes, these sensor components must also include biorecognition elements that can directly detect biologically relevant analytes. These biorecognition elements can be natural proteins, peptides or nucleic acids. They must also be compatible with the operating mode of the sensor and its application.
In detecting respiratory illnesses
Using sensors in clinical trials is not only less invasive than other methods, but it also improves the accuracy of results. Sensors can collect data from various chemical components in the body, including sweat, urine, and blood. They can also measure emotional or behavioral responses, which helps researchers understand how a treatment works.
These devices can provide a real-time monitoring system and transmit the collected data to a central server. They can also be used for point-of-care (POC) diagnostics in hospitals. They can monitor symptoms that affect health, including respiratory illnesses and cardiac diseases. They can also be used to detect neurological disorders, such as epilepsy and Parkinson’s disease.
These devices are based on different technologies, including sensor technology, medical chip technology, wireless communication, and power management technology. They are small and compact, making them easy to use and maintain. They are also able to detect multiple biopotentials, such as electrocardiogram (ECG), electrooculogram (EOG), and movement.
In detecting sleep apnea
The latest developments in telecommunication technologies, materials science, bioengineering, electronics and data analysis have made it possible to create wearable sensors that can perform complex analytics and detect physiological changes. Some of these devices are available for clinical use, but others have not yet been tested in a large number of patients. In addition, some devices are marketed without sufficient evidence of their efficacy, and unsubstantiated claims may mislead consumers.
The majority of wearable sensor types employ biorecognition sensing elements that convert chemical or biological analytes into a signal. The most common detection modalities are electromechanical, electrical and optical techniques, which can provide continuous streams of data over days or weeks and require minimal power.
The next step is to integrate the information gathered by these devices into clinical decision support (CDS) software programs. This will improve their utility and accuracy. User preferences must also be considered to ensure that a sensor system can gain acceptance both in the clinical and home environments.
OnePhenix is the only IPAAS software that connects your wearable data to your healthcare professionals. www.Onephenix.com.au